Co-Diagnostics, Inc. (CODX)
USD 0.32
(-9.78%)
USD 0.32
(-9.78%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 44.1 Million USD | 9.36% |
| 2022 | 40.32 Million USD | 0.21% |
| 2021 | 40.24 Million USD | 147.4% |
| 2020 | 16.26 Million USD | 171.3% |
| 2019 | 5.99 Million USD | -2.47% |
| 2018 | 6.14 Million USD | 34.49% |
| 2017 | 4.57 Million USD | 170.82% |
| 2016 | 1.68 Million USD | -14.66% |
| 2015 | 1.97 Million USD | 91.22% |
| 2014 | 1.03 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 9.78 Million USD | -3.7% |
| 2024 Q1 | 10.16 Million USD | -16.01% |
| 2023 FY | 44.1 Million USD | 9.36% |
| 2023 Q1 | 10.05 Million USD | -13.5% |
| 2023 Q2 | 11.73 Million USD | 16.74% |
| 2023 Q3 | 11.13 Million USD | -5.08% |
| 2023 Q4 | 12.09 Million USD | 8.64% |
| 2022 Q2 | 8.25 Million USD | -13.95% |
| 2022 FY | 40.32 Million USD | 0.21% |
| 2022 Q4 | 11.61 Million USD | 6.96% |
| 2022 Q3 | 10.86 Million USD | 31.59% |
| 2022 Q1 | 9.59 Million USD | 26.13% |
| 2021 Q1 | 6.41 Million USD | -5.67% |
| 2021 FY | 40.24 Million USD | 147.4% |
| 2021 Q4 | 7.6 Million USD | -42.21% |
| 2021 Q3 | 13.15 Million USD | 0.75% |
| 2021 Q2 | 13.06 Million USD | 103.55% |
| 2020 Q3 | 3.95 Million USD | 17.95% |
| 2020 FY | 16.26 Million USD | 171.3% |
| 2020 Q4 | 6.8 Million USD | 71.83% |
| 2020 Q2 | 3.35 Million USD | 56.22% |
| 2020 Q1 | 2.14 Million USD | 27.97% |
| 2019 Q1 | 1.25 Million USD | -31.09% |
| 2019 Q4 | 1.67 Million USD | 0.48% |
| 2019 Q2 | 1.38 Million USD | 10.43% |
| 2019 Q3 | 1.67 Million USD | 20.35% |
| 2019 FY | 5.99 Million USD | -2.47% |
| 2018 Q3 | 1.67 Million USD | 22.77% |
| 2018 FY | 6.14 Million USD | 34.49% |
| 2018 Q1 | 1.28 Million USD | -13.98% |
| 2018 Q2 | 1.36 Million USD | 5.9% |
| 2018 Q4 | 1.82 Million USD | 9.04% |
| 2017 Q4 | 1.49 Million USD | -17.23% |
| 2017 Q1 | 564.36 Thousand USD | 26.94% |
| 2017 FY | 4.57 Million USD | 170.82% |
| 2017 Q3 | 1.8 Million USD | 157.09% |
| 2017 Q2 | 703.11 Thousand USD | 24.59% |
| 2016 Q3 | 392.35 Thousand USD | 0.53% |
| 2016 Q1 | 460.74 Thousand USD | 0.29% |
| 2016 FY | 1.68 Million USD | -14.66% |
| 2016 Q4 | 444.57 Thousand USD | 13.31% |
| 2016 Q2 | 390.29 Thousand USD | -15.29% |
| 2015 FY | 1.97 Million USD | 91.22% |
| 2015 Q4 | 459.4 Thousand USD | 0.0% |
| 2014 FY | 1.03 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Acutus Medical, Inc. | 11.22 Million USD | -292.933% |
| Cerus Corporation | 143.15 Million USD | 69.192% |
| OrthoPediatrics Corp. | 137.01 Million USD | 67.813% |
| PetVivo Holdings, Inc. | 11.36 Million USD | -288.2% |
| Talis Biomedical Corporation | 67.18 Million USD | 34.357% |
| Vivos Therapeutics, Inc. | 24.94 Million USD | -76.793% |
| Inogen, Inc. | 236.08 Million USD | 81.319% |
| Spectral AI, Inc. | 20.86 Million USD | -111.383% |
| Nano-X Imaging Ltd. | 55.99 Million USD | 21.241% |
| CVRx, Inc. | 76.14 Million USD | 42.078% |
| DIH Holding US, Inc. Warrants | 3.52 Million USD | -1150.082% |
| Helius Medical Technologies, Inc. | 12.48 Million USD | -253.134% |
| Orthofix Medical Inc. | 667.42 Million USD | 93.392% |
| Venus Concept Inc. | 80.47 Million USD | 45.198% |
| Accelerate Diagnostics, Inc. | 56.57 Million USD | 22.049% |
| Bioventus Inc. | 409.91 Million USD | 89.241% |
| BrainsWay Ltd. | 28.01 Million USD | -57.409% |
| Envoy Medical, Inc. | 17.89 Million USD | -146.412% |
| electroCore, Inc. | 32.03 Million USD | -37.688% |
| IceCure Medical Ltd | 16.87 Million USD | -161.335% |
| Lucid Diagnostics Inc. | 42.43 Million USD | -3.938% |
| Monogram Orthopaedics, Inc. | 17.63 Million USD | -150.115% |
| MaxCyte, Inc. | 84.84 Million USD | 48.02% |
| NeuroOne Medical Technologies Corporation | 12.41 Million USD | -255.331% |
| Nexalin Technology, Inc. | 5.78 Million USD | -662.846% |
| PAVmed Inc | 64.82 Million USD | 31.968% |
| Rapid Micro Biosystems, Inc. | 51.07 Million USD | 13.656% |
| RxSight, Inc. | 103.85 Million USD | 57.532% |
| Sight Sciences, Inc. | 126.44 Million USD | 65.122% |
| SI-BONE, Inc. | 156.35 Million USD | 71.792% |
| TELA Bio, Inc. | 84.18 Million USD | 47.613% |
| TriSalus Life Sciences, Inc. | 70.05 Million USD | 37.046% |
| Treace Medical Concepts, Inc. | 203.36 Million USD | 78.313% |
| LivaNova PLC | 843.54 Million USD | 94.772% |
| 908 Devices Inc. | 68.08 Million USD | 35.219% |
| Alphatec Holdings, Inc. | 483.59 Million USD | 90.88% |
| Nemaura Medical Inc. | 7.13 Million USD | -517.791% |
| NeuroPace, Inc. | 75.29 Million USD | 41.427% |
| LENSAR, Inc. | 33.33 Million USD | -32.298% |
| Apyx Medical Corporation | 51.01 Million USD | 13.554% |
| Cutera, Inc. | 197.72 Million USD | 77.695% |
| STRATA Skin Sciences, Inc. | 24.78 Million USD | -77.97% |
| BioSig Technologies, Inc. | 28.53 Million USD | -54.584% |
| Anika Therapeutics, Inc. | 191.47 Million USD | 76.967% |
| ClearPoint Neuro, Inc. | 36.06 Million USD | -22.304% |
| Integra LifeSciences Holdings Corporation | 836.39 Million USD | 94.727% |
| Axonics, Inc. | 270.2 Million USD | 83.678% |
| Outset Medical, Inc. | 198.77 Million USD | 77.812% |
| IRIDEX Corporation | 31.81 Million USD | -38.627% |
| PROCEPT BioRobotics Corporation | 180.21 Million USD | 75.528% |
| IRadimed Corporation | 30.12 Million USD | -46.41% |
| Tivic Health Systems, Inc. | 8.53 Million USD | -416.911% |
| INVO Bioscience, Inc. | 7.85 Million USD | -461.584% |
| Telesis Bio, Inc. | 63.48 Million USD | 30.535% |
| Viemed Healthcare, Inc. | 98.45 Million USD | 55.204% |
| Varex Imaging Corporation | 224.8 Million USD | 80.381% |
| Quipt Home Medical Corp. | 148.66 Million USD | 70.334% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | -276.208% |
| Pulmonx Corporation | 112.68 Million USD | 60.863% |
| Dynatronics Corporation | 9.9 Million USD | -345.122% |
| Modular Medical, Inc. | 17.52 Million USD | -151.599% |
| ReShape Lifesciences Inc. | 20.18 Million USD | -118.472% |
| Semler Scientific, Inc. | 38.94 Million USD | -13.247% |
| InMode Ltd. | 215.68 Million USD | 79.552% |
| Bruker Corporation | 1.07 Billion USD | 95.903% |
| Cytosorbents Corporation | 48.33 Million USD | 8.759% |
| DexCom, Inc. | 1.69 Billion USD | 97.392% |
| Align Technology, Inc. | 2.07 Billion USD | 97.876% |
| Viveve Medical, Inc. | 22.17 Million USD | -98.903% |
| ZimVie Inc. | 275.12 Million USD | 83.97% |
| Movano Inc. | 29.69 Million USD | -48.544% |
| Cytek Biosciences, Inc. | 137.27 Million USD | 67.872% |
| Nexalin Technology, Inc. | 5.78 Million USD | -662.846% |
| DIH Holdings US, Inc. Class A Common Stock | 3.52 Million USD | -1150.082% |
| Tandem Diabetes Care, Inc. | 600.92 Million USD | 92.661% |
| Profound Medical Corp. | 33.6 Million USD | -31.246% |
| Insulet Corporation | 939.9 Million USD | 95.308% |
| enVVeno Medical Corporation | 25.23 Million USD | -74.748% |
| Surmodics, Inc. | 98.69 Million USD | 55.315% |
| iCAD, Inc. | 22.22 Million USD | -98.438% |
| Nuwellis, Inc. | 22.61 Million USD | -95.033% |
| Biotricity, Inc. | 17.18 Million USD | -156.642% |
| iRhythm Technologies, Inc. | 445.88 Million USD | 90.109% |
| Aethlon Medical, Inc. | 12.27 Million USD | -259.217% |
| InspireMD, Inc. | 22.95 Million USD | -92.169% |
| PAVmed Inc. | 64.82 Million USD | 31.968% |
| BIOLASE, Inc. | 34.66 Million USD | -27.241% |
| Beyond Air, Inc. | 61.7 Million USD | 28.521% |
| FONAR Corporation | 28.6 Million USD | -54.181% |
| AxoGen, Inc. | 149.33 Million USD | 70.467% |
| Vivani Medical, Inc. | 26.96 Million USD | -63.556% |
| Tactile Systems Technology, Inc. | 177.09 Million USD | 75.096% |
| Inari Medical, Inc. | 448.59 Million USD | 90.169% |
| UFP Technologies, Inc. | 58.08 Million USD | 24.077% |
| QT Imaging Holdings, Inc. | 4.92 Million USD | -795.017% |
| Heart Test Laboratories, Inc. | 6.31 Million USD | -598.019% |
| Tenon Medical, Inc. | 16.96 Million USD | -159.918% |
| Autonomix Medical, Inc. Common Stock | 7.39 Million USD | -496.549% |
| AdaptHealth Corp. | 1.07 Billion USD | 95.909% |
| Sintx Technologies, Inc. | 15.2 Million USD | -190.131% |
| NanoVibronix, Inc. | 4.97 Million USD | -786.846% |
| Quanterix Corporation | 118.1 Million USD | 62.656% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | -276.208% |
| Sensus Healthcare, Inc. | 14.44 Million USD | -205.379% |
| Pacific Biosciences of California, Inc. | 392.66 Million USD | 88.768% |
| TransMedics Group, Inc. | 182.82 Million USD | 75.876% |
| ReWalk Robotics Ltd. | 28.06 Million USD | -57.145% |
| NeuroMetrix, Inc. | 11.09 Million USD | -297.361% |
| Hyperfine, Inc. | 52.87 Million USD | 16.586% |
| Establishment Labs Holdings Inc. | 172 Million USD | 74.359% |
| Biomerica, Inc. | 6.97 Million USD | -532.027% |
| Bone Biologics Corporation | 9.42 Million USD | -367.771% |
| AVITA Medical, Inc. | 80.77 Million USD | 45.403% |
| Bluejay Diagnostics, Inc. | 10.31 Million USD | -327.717% |
| Silk Road Medical, Inc | 186.35 Million USD | 76.334% |